Sao Tome and Principe vs Saudi Arabia: HIV-positive TB patients on ART (antiretroviral therapy)
Sao Tome and Principe
100.0%
in 2024
Saudi Arabia
100.0%
in 2024
Sao Tome and Principe rank
1st
Saudi Arabia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sao Tome and Principe
- Saudi Arabia
How they compare
Sao Tome and Principe currently reports 100.0% against 100.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 2 times across 11 shared years of data; in 2007 it was Saudi Arabia ahead.
Sao Tome and Principe ranks 1st and Saudi Arabia ranks 1st of 144 countries.
Across the 3 decades both report, Sao Tome and Principe averaged higher in 1 and Saudi Arabia in 1.
Head to head by decade
| Decade | Sao Tome and Principe | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.0% | 100.0% | 64.0% | Saudi Arabia |
| 2010s | 100.0% | 99.0% | 1.0% | Sao Tome and Principe |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sao Tome and Principe or Saudi Arabia?
- Sao Tome and Principe, at 100.0% against 100.0% in Saudi Arabia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sao Tome and Principe and Saudi Arabia?
- 0.0%, with Sao Tome and Principe ahead.
- How many years of comparable data are there for Sao Tome and Principe and Saudi Arabia?
- 11 years are reported by both, from 2007 to 2024.
- How do Sao Tome and Principe and Saudi Arabia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sao Tome and Principe ranks 1st and Saudi Arabia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.